霧化器市場規模、佔有率和成長分析（按類型、模式、應用、最終用途和地區）- 產業預測 2025-2032

預計到 2023 年霧化器市場規模將達到 12.3 億美元，並從 2024 年的 13.1 億美元成長到 2032 年的 21 億美元，預測期內（2025-2032 年）的複合年成長率為 6.1%。

由於慢性呼吸系統疾病盛行率上升、家庭醫療保健需求增加以及人口老化等多種因素，霧化器市場正在經歷強勁成長。其中，慢性阻塞性肺病（COPD）在美國死因中排名第四，其主要原因是吸菸、食用加工食品等生活習慣。根據疾病預防控制中心的報告，北美30-70歲成年人的死亡中約有14%與吸菸有關，凸顯了呼吸系統疾病與霧化器需求之間的關聯。在全球整體，COPD 導致約 323 萬人死亡，然而，全球對抗慢性呼吸系統疾病聯盟等措施有望加強診斷和治療，進一步增加霧化器市場的成長潛力。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

霧化器市場規模（按類型和複合年成長率）（2025-2032）

• 市場概況
• 噴射
• 網
  • 積極的
  • 被動的
• 超音波

霧化器市場規模（按模式和複合年成長率） (2025-2032)

• 市場概況
• 可攜式的
• 桌面

霧化器市場規模（按應用和複合年成長率） (2025-2032)

• 市場概況
• 慢性阻塞性肺病
• 囊腫纖維化
• 氣喘
• 其他

霧化器市場規模（依最終用途和複合年成長率） (2025-2032)

• 市場概況
• 醫院和診所
• 急診中心
• 家庭醫療保健

霧化器市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Omron Corporation（Japan）
• Allied Healthcare（United Kingdom）
• Teleflex Incorporated（United States）
• Briggs Healthcare（United States）
• Aerogen（Ireland）
• Medtronic Plc（Ireland）
• GE Healthcare（United States）
• DeVilbiss Healthcare LLC（United States）
• Koninklijke Philips NV（Netherlands）
• Vectura Group Plc.（United Kingdom）
• PARI Respiratory Equipment, Inc.（Germany）
• Beurer GmbH（Germany）
• Covidien plc（Ireland）
• Becton, Dickinson and Company（BD）（United States）
• Rossmax International Ltd.（Taiwan）
• Nulife Global Medical Devices（India）
• BPL Medical Technologies（India）
• Agaro（India）
• Medline Industries, LP（United States）
• Drive DeVilbiss Healthcare（United States）

結論和建議

Nebulizer Market size was valued at USD 1.23 billion in 2023 and is poised to grow from USD 1.31 billion in 2024 to USD 2.1 billion by 2032, growing at a CAGR of 6.1% during the forecast period (2025-2032).

The Nebulizer market is experiencing robust growth driven by several factors including the rising prevalence of chronic respiratory diseases, increased demand for home healthcare, and an aging population. Chronic Obstructive Pulmonary Disease (COPD) is particularly concerning, ranking as the fourth leading cause of death in the U.S., largely due to lifestyle factors like tobacco and processed product consumption. The CDC reports that around 14% of deaths in adults aged 30-70 in North America are related to tobacco use, emphasizing the link between respiratory diseases and nebulizer demand. Globally, COPD accounts for approximately 3.23 million deaths, but initiatives like the "Global Alliance against Chronic Respiratory Diseases" are expected to enhance diagnosis and treatment, further boosting the nebulizer market's growth potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Nebulizer market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Nebulizer Market Segments Analysis

Global Nebulizer Market is segmented by Type, Modality, Application, End-use and region. Based on Type, the market is segmented into Jet, Mesh and Ultrasonic. Based on Modality, the market is segmented into Portable and Table-top. Based on Application, the market is segmented into COPD, Cystic Fibrosis, Asthma and Others. Based on End-use, the market is segmented into Hospitals And Clinics, Emergency Centers and Home Healthcare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Nebulizer Market

The increasing prevalence of respiratory ailments, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis, serves as a major driver for the nebulizer market. These health conditions necessitate efficient medication delivery systems to effectively reach the respiratory tract, making nebulizers an essential tool in administering treatments directly to the lungs. As more individuals are diagnosed with these diseases, the demand for nebulizers continues to rise, further boosting the market's growth. This trend highlights the critical role that nebulizers play in enhancing patient care and improving respiratory health outcomes, thereby solidifying their position in the healthcare industry.

Restraints in the Nebulizer Market

The nebulizer market faces significant restraints due to the limitations and inconsistencies in reimbursement policies for nebulizer treatments. This inadequacy in comprehensive coverage can hinder both affordability and accessibility, making it challenging for patients to acquire the necessary nebulizer devices and medications. As a result, many patients encounter obstacles when seeking nebulizer therapy, which ultimately restricts the overall growth potential of the market. Without reliable reimbursement options, the demand for nebulizers may stagnate, impacting manufacturers and healthcare providers alike. Such barriers must be addressed to foster a more supportive environment for both patients and the nebulizer market as a whole.

Market Trends of the Nebulizer Market

The nebulizer market is witnessing a significant trend towards technological innovation, characterized by the increasing adoption of mesh nebulizers that leverage advanced vibrating mesh technology. This shift has resulted in devices that not only deliver medications more efficiently but are also compact and portable, catering to the growing demand for convenience among users. As drug delivery systems evolve, these improvements are enhancing the overall patient experience by minimizing drug loss and optimizing treatment outcomes. Additionally, the rise in respiratory diseases and the focus on personalized healthcare solutions are expected to further drive market growth, making nebulizers a vital component of modern respiratory therapy.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Nebulizer Market Size by Type & CAGR (2025-2032)

• Market Overview
• Jet
• Mesh
  • Active
  • Passive
• Ultrasonic

Global Nebulizer Market Size by Modality & CAGR (2025-2032)

• Market Overview
• Portable
• Table-top

Global Nebulizer Market Size by Application & CAGR (2025-2032)

• Market Overview
• COPD
• Cystic Fibrosis
• Asthma
• Others

Global Nebulizer Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Hospitals And Clinics
• Emergency Centers
• Home Healthcare

Global Nebulizer Market Size & CAGR (2025-2032)

• North America (Type, Modality, Application, End-use)
  • US
  • Canada
• Europe (Type, Modality, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Modality, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Modality, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Modality, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Omron Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allied Healthcare (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Briggs Healthcare (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aerogen (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DeVilbiss Healthcare LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vectura Group Plc. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PARI Respiratory Equipment, Inc. (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beurer GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Covidien plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rossmax International Ltd. (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nulife Global Medical Devices (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BPL Medical Technologies (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agaro (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medline Industries, LP (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Drive DeVilbiss Healthcare (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations